Aehr Test Systems (AEHR) Stock Forecast, Price & News

1 Wall Street analysts have issued "buy," "hold," and "sell" ratings for Aehr Test Systems in the last twelve months. There are currently 1 buy rating for the stock. The consensus among Wall Street analysts is that investors should "buy" AEHR shares.
View AEHR analyst ratings or view top-rated stocks.

1 analysts have issued 1-year target prices for Aehr Test Systems' stock. Their AEHR share price forecasts range from $60.00 to $60.00. On average, they predict the company's share price to reach $60.00 in the next year. This suggests a possible upside of 29.1% from the stock's current price.
View analysts price targets for AEHR or view top-rated stocks among Wall Street analysts.

Aehr Test Systems' stock was trading at $20.10 at the start of the year. Since then, AEHR stock has increased by 131.2% and is now trading at $46.47.
View the best growth stocks for 2023 here.

Aehr Test Systems saw a decrease in short interest in the month of September. As of September 15th, there was short interest totaling 4,840,000 shares, a decrease of 12.2% from the August 31st total of 5,510,000 shares. Based on an average trading volume of 1,050,000 shares, the short-interest ratio is currently 4.6 days.
View Aehr Test Systems' Short Interest.

The company is scheduled to release its next quarterly earnings announcement on Thursday, October 5th 2023.
View our AEHR earnings forecast.

Aehr Test Systems will be holding an earnings conference call on Thursday, October 5th at 5:00 PM Eastern. Interested parties can register for or listen to the call using this link or dial in at 412-317-0088 with passcode "3262937".

Aehr Test Systems (NASDAQ:AEHR) announced its quarterly earnings results on Thursday, July, 13th. The semiconductor company reported $0.21 EPS for the quarter, topping analysts' consensus estimates of $0.17 by $0.04. The semiconductor company had revenue of $22.27 million for the quarter, compared to analyst estimates of $21.30 million. Aehr Test Systems had a net margin of 22.41% and a trailing twelve-month return on equity of 23.07%.

ETFs with the largest weight of Aehr Test Systems (NASDAQ:AEHR) stock in their portfolio include Clough Select Equity ETF (CBSE), Clough Long/Short Equity ETF (CBLS), SPDR FactSet Innovative Technology ETF (XITK), Invesco DWA SmallCap Momentum ETF (DWAS), Invesco Nasdaq Future Gen 200 ETF (QQQS), Barrons 400 ETF (BFOR) and iShares Micro-Cap ETF (IWC).Inspire Small/Mid Cap ETF (ISMD).

Aehr Test Systems updated its FY earnings guidance on Sunday, July, 16th. The company provided EPS guidance of for the period. The company issued revenue guidance of $100.00M-, compared to the consensus revenue estimate of $102.58 million.

1 employees have rated Aehr Test Systems Chief Executive Officer Rhea J. Posedel on Glassdoor.com. Rhea J. Posedel has an approval rating of 100% among the company's employees. This puts Rhea J. Posedel in the top 10% of approval ratings compared to other CEOs of publicly-traded companies.

Based on aggregate information from My MarketBeat watchlists, some companies that other Aehr Test Systems investors own include Arbutus Biopharma (ABUS), Co-Diagnostics (CODX), iBio (IBIO), Inovio Pharmaceuticals (INO), Palatin Technologies (PTN), Tonix Pharmaceuticals (TNXP), T2 Biosystems (TTOO), Vaxart (VXRT), Aclaris Therapeutics (ACRS) and Acasti Pharma (ACST).

Aehr Test Systems trades on the NASDAQ under the ticker symbol "AEHR."

Aehr Test Systems' stock is owned by a number of retail and institutional investors. Top institutional investors include BlackRock Inc. (6.46%), Goldman Sachs Group Inc. (4.98%), Driehaus Capital Management LLC (4.76%), AWM Investment Company Inc. (4.54%), State Street Corp (1.95%) and Geode Capital Management LLC (1.83%). Insiders that own company stock include Alistair N Sporck, David S Hendrickson, Donald P Richmond II, Gayn Erickson, Geoffrey Gates Scott, Howard T Slayen, Kenneth B Spink, Kenneth B Spink, Laura Oliphant, Mario M Rosati, Mario M Rosati, Michael A Brannan, Rhea J Posedel and Vernon Rogers.
View institutional ownership trends.

Shares of AEHR stock can be purchased through any online brokerage account. Popular online brokerages with access to the U.S. stock market include WeBull, Vanguard Brokerage Services, TD Ameritrade, E*TRADE, Robinhood, Fidelity, and Charles Schwab.
Compare Top Brokerages Here.

One share of AEHR stock can currently be purchased for approximately $46.47.

Aehr Test Systems (NASDAQ:AEHR) has a market capitalization of $1.34 billion and generates $64.96 million in revenue each year. The semiconductor company earns $14.56 million in net income (profit) each year or $0.50 on an earnings per share basis.

The company employs 104 workers across the globe.

Aehr Test Systems' mailing address is 400 KATO TERRACE, FREMONT CA, 94539. The official website for the company is www.aehr.com. The semiconductor company can be reached via phone at (510) 623-9400, via email at aehr@mkr-group.com, or via fax at 510-623-9450.